Surya Pharmaceutical Ltd


BSE: 532516 | NSE: SURYAPHARM | ISIN: INE249G01020 
Market Cap: [Rs.Cr.] 23 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Annual Results

ParticularsMar-12
(Rs.Cr) 
Mar-11
(Rs.Cr) 
Mar-10
(Rs.Cr) 
Gross Sales 1,6231,6001,134
Other Income  030
Total Income 1,5851,6031,145
Total Expenditure  1,7781,347971
PBIDT -193256173
Interest  1669862
PBDT -359158111
Depreciation 352721
Tax 03215
Deferred Tax -1210-1
Reported Profit After Tax -27310076
Extra-ordinary Items  000
Adjusted Profit After Extra-ordinary item -27310076
    
EPS (Unit Curr.) -13.45.152.6
EPS (Adj) (Unit Curr.) -13.45.15.3
Calculated EPS (Unit Curr.) 0.05.252.6
Calculated EPS (Adj) (Unit Curr.) 0.05.25.3
Calculated EPS (Ann.) (Unit Curr.) 0.05.252.6
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.05.25.3
Book Value (Unit Curr.) 0.00.00.0
Dividend (%) 0.015.015.0
Equity 201914
Reserve & Surplus 227.2494.1288.7
Face Value 1.01.010.0
    
Non-Promoter Holding Shares 125,488,750125,488,7508,691,975
Non-Promoter Holding (%) 61.8965.1060.08
    
PBIDTM(%) -11.8816.0015.29
PBDTM(%) -22.109.899.79
PATM(%) -16.796.266.71
 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 100,416.95 69.76 12.38 27.45 26.1 27.0 0.01
Dr Reddy's Labs 35,071.23 27.71 4.61 18.79 14.3 16.6 0.25
Cipla 32,778.39 21.41 4.35 14.11 15.9 19.8 0.03
Ranbaxy Labs. 16,513.59 0.00 8.60 72.87 0.0 0.0 2.38
Cadila Health. 16,249.19 39.39 6.37 18.45 28.4 24.2 0.40
Glenmark Pharma. 14,932.01 38.68 5.92 23.94 12.7 11.7 0.39
Wockhardt 13,475.05 80.27 111.99 12.82 237.0 30.3 2.09
Piramal Enterp. 9,623.98 0.00 0.91 23.66 0.8 2.1 0.07
Ipca Labs. 7,202.23 21.66 5.71 10.09 24.2 23.7 0.49
Torrent Pharma. 6,125.22 11.46 4.70 11.66 29.6 25.5 0.48
Biocon 5,488.00 19.14 2.49 12.20 12.6 13.6 0.08
Strides Arcolab 5,270.21 35.93 3.84 46.94 7.3 8.9 0.56
Aurobindo Pharma 4,995.54 11.88 2.00 22.89 10.7 8.8 1.01
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,222.42 14.12 4.83 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Alka Goyal , Executive Director 

Rajiv Goyal , Chairman & Managing Director 

D P Singhal , Independent Director 

S K Yadav , Additional Director 


Company Head Office / Quarters:
1596 1st Floor,
Bhagirath Palace,
Delhi,
Delhi-110006
Phone :
Fax :
E-mail :
sales@suryapharma.com
rajivg@suryapharma.com
Web : http://www.suryapharma.com
Registrars:
Big Share Services Pvt Ltd
E-2/3 Saki Vihar Rd
Ansa Indl Estate
Saki Naka Andheri-E
Mumbai - 400 072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list Bank of Japan April 26 meeting minutes
list BOJ Governor Kuroda Speech in Tokyo
Results
list No result today